The thyrotropin-releasing hormone (TRH)-immune system homeostatic hypothesis

Pharmacology and Therapeutics

Volumn 121, Issue 1, 2009, Pages 20-28

  Kamath, J ^a   Yarbrough, G G ^b   Prange Jr , A J ^c   Winokur, A ^a  

^a UNIVERSITY OF CONNECTICUT HEALTH CENTER   (United States)

^b TRH Therapeutics LLC   (United States)

^c UNIVERSITY OF NORTH CAROLINA   (United States)

Author keywords

cytokine; Homeostasis; Immune; Inflammation; Thyrotropin releasing hormone; TRH

Indexed keywords

MONTIRELIN; PROTIRELIN; PROTIRELIN DERIVATIVE; PROTIRELIN RECEPTOR; PROTIRELIN[3 (3,3 DIMETHYLPROLINAMIDE)]; TALTIRELIN;

AUTOCRINE EFFECT; CYTOKINE PRODUCTION; DRUG MECHANISM; HOMEOSTASIS; HORMONE ACTION; HUMAN; HYPOTHESIS; IMMUNE SYSTEM; IMMUNOMODULATION; IMMUNOPATHOLOGY; INFLAMMATION; NONHUMAN; PARACRINE SIGNALING; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN LOCALIZATION; REVIEW; THERAPY EFFECT;

ANIMALS; CENTRAL NERVOUS SYSTEM; DRUG DISCOVERY; HOMEOSTASIS; HUMANS; IMMUNE SYSTEM PROCESSES; INFLAMMATION; MODELS, IMMUNOLOGICAL; NEUROIMMUNOMODULATION; RECEPTORS, THYROTROPIN-RELEASING HORMONE; THYROTROPIN-RELEASING HORMONE;

EID: 57749109003     PISSN: 01637258     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pharmthera.2008.09.004     Document Type: Review

References (89)

1. Ader R. Presidential address: psychosomatic and psychoimmunologic research. Psychosom Med 42 (1980) 307-322
2. Bayliss D.A., Viana F., Kanter R.K., Szymeczek-Seay C.L., Berger A.J., and Millhorn D.E. Early postnatal development of thyrotropin-releasing hormone (TRH) expression, TRH receptor binding, and TRH responses in neurons of rat brainstem. J Neurosci 14 2 (1994) 821-833
3. Ben-Jonathan N., Mershon J., Allen D., and Steinmetz R. Extrapituitary prolactin: distribution, regulation, functions and clinical aspects. Endocr Rev 17 (1996) 639-669
4. Bilek R. TRH-like peptides in prostate gland and other tissues. Physiol Res 49 Suppl 1 (2000) 519-526
5. Błaszkowska J., Pawlikowski M., Komorowski J., and Kurnatowski P. Effect of thyroliberin on the course of experimental candidosis in mice. Mycoses 47 3-4 (2004) 115-120
6. Bluthé R.M., Michaud B., Kelley K.W., and Dantzer R. Vagotomy blocks behavioral effects of interleukin-1 injected via the intraperitoneal route but not via other systemic routes. Neuroreport 7 15-17 (1996) 2823-2827
7. Boelen A., Kwakkel J., Thijssen-Timmer D.C., Alkemade A., Fliers E., and Wiersinga W.M. Simultaneous changes in central and peripheral components of the hypothalamus-pituitary-thyroid axis in lipopolysaccharide-induced acute illness in mice. J Endocrinol 182 2 (2004) 315-323
8. Boelen A., Kwakkel J., Wiersinga W.M., and Fliers E. Chronic local inflammation in mice results in decreased TRH and type 3 deiodinase mRNA expression in the hypothalamic paraventricular nucleus independently of diminished food intake. J Endocrinol 191 3 (2006) 707-714
9. Bower J.E. Cancer-related fatigue: links with inflammation in cancer patients and survivors. Brain Behav Immun 21 7 (2007) 863-871
10. Dantzer R., and Kelley K.W. Twenty years of research on cytokine-induced sickness behavior. Brain Behav Immun 21 2 (2007) 153-160
11. Elenkov I.J., Iezzoni D.G., Daly A., Harris A.G., and Chrousos G.P. Cytokine dysregulation, inflammation and well-being. Neuroimmunomodulation 12 5 (2005) 255-269
12. Ericsson A., Kovács K.J., and Sawchenko P.E. A functional anatomical analysis of central pathways subserving the effects of interleukin-1 on stress-related neuroendocrine neurons. J Neurosci 14 2 (1994) 897-913
13. Eskandari F., and Sternberg E.M. Neural-immune interactions in health and disease. Ann N Y Acad Sci 966 (2002) 20-27
14. Fekete C., Singru P.S., Sarkar S., Rand W.M., and Lechan R.M. Ascending brainstem pathways are not involved in lipopolysaccharide-induced suppression of thyrotropin-releasing hormone gene expression in the hypothalamic paraventricular nucleus. Endocrinology 146 3 (2005) 1357-1363
15. Fukusumi S., Ogi K., Onda H., and Hinuma S. Distribution of thyrotropin-releasing hormone receptor mRNA in rat peripheral tissues. Regul Pept 57 2 (1995) 115-121
16. Gary K.A., Sevarino K.A., Yarbrough G.G., Prange Jr. A.J., and Winokur A. The thyrotropin-releasing hormone (TRH) hypothesis of homeostatic regulation: implications for TRH-based therapeutics. J Pharmacol Exp Ther 305 2 (2003) 410-416
17. Gaykema R.P., Chen C.C., and Goehler L.E. Organization of immune-responsive medullary projections to the bed nucleus of the stria terminalis, central amygdala, and paraventricular nucleus of the hypothalamus: evidence for parallel viscerosensory pathways in the rat brain. Brain Res 1130 1 (2007) 130-145
18. Gershengorn M.C., and Osman R. Molecular and cellular biology of thyrotropin-releasing hormone receptors. Physiol Rev 76 1 (1996) 175-191
19. Grasso G., Massai L., De Leo V., and Muscettola M. The effect of LHRH and TRH on human interferon-gamma production in vivo and in vitro. Life Sci 62 22 (1998) 2005-2014
20. Guillemin R. Peptides in the brain: the new endocrinology of the neuron. Science 202 (1978) 390-402
21. Hart R., Wagner F., Steffens W., Lersch C., Dancygier H., Duntas L., et al. Effect of thyrotropin-releasing hormone on immune functions of peripheral blood mononuclear cells. Regul Pept 27 3 (1990) 335-342
22. Hermann G., and Rogers R.C. Tumor necrosis factor-alpha in the dorsal vagal complex suppresses gastric motility. Neuroimmunomodulation 2 2 (1995) 74-81
23. Hermann G.E., Tovar C.A., and Rogers R.C. Induction of endogenous tumor necrosis factor-alpha: suppression of centrally stimulated gastric motility. Am J Physiol 276 1 Pt 2 (1999) R59-68
24. Heuer H., Schäfer M.K., O'Donnell D., Walker P., and Bauer K. Expression of thyrotropin-releasing hormone receptor 2 (TRH-R2) in the central nervous system of rats. J Comp Neurol 428 2 (2000) 319
25. Jacobsen P.B., and Thors C.L. Fatigue in the radiation therapy patient: current management and investigations. Semin Radiat Oncol 13 3 (2003) 372-380
26. Kawakubo K., Akiba Y., Adelson D., Guth P.H., Engel E., Taché Y., et al. Role of gastric mast cells in the regulation of central TRH analog-induced hyperemia in rats. Peptides 26 9 (2005) 1580-1589
27. Keller S.E., Schleifer S.J., Liotta A.S., Bond R.N., Farhoody N., and Stein M. Stress-induced alterations of immunity in hypophysectomized rats. Proc Natl Acad Sci U S A 85 23 (1988) 9297-9301
28. Kelley K.W., Bluthé R.M., Dantzer R., Zhou J.H., Shen W.H., Johnson R.W., et al. Cytokine-induced sickness behavior. Brain Behav Immun 17 Suppl 1 (2003) S112-118
29. Kelley K.W., Weigent D.A., and Kooijman R. Protein hormones and immunity. Brain Behav Immun 21 4 (2007) 384-392
30. Klein J.R. Physiological relevance of thyroid stimulating hormone and thyroid stimulating hormone receptor in tissues other than the thyroid. Autoimmunity 36 6-7 (2003) 417-421
31. Klein J.R. The immune system as a regulator of thyroid hormone activity. Exp Biol Med (Maywood) 231 3 (2006) 229-236
32. Komorowski J., Stepień H., and Pawlikowski M. The evidence of thyroliberin/triiodothyronine control of TSH secretory response from human peripheral blood monocytes cultured in vitro. Neuropeptides 25 1 (1993) 31-34
33. Komorowski J., Stepien H., and Pawlikowski M. Increased interleukin-2 levels during standard TRH test in man. Neuropeptides 27 (1994) 151-156
34. Kruger T.E. Immunomodulation of peripheral lymphocytes by hormones of the hypothalamus-pituitary-thyroid axis. Adv Neuroimmunol 6 4 (1996) 387-395
35. Kubera M., Kenis G., Bosmans E., Jaworska-Feil L., Lasoń W., Scharpe S., et al. Suppressive effect of TRH and imipramine on human interferon-gamma and interleukin-10 production in vitro. Pol J Pharmacol 52 6 (2000) 481-486
36. Kruger T.E., Smith L.R., Harbour D.V., and Blalock J.E. Thyrotropin:an endogenous regulator of the in vitro immune response. J Immunol 142 3 (1989) 744-747
37. Kunert-Radek J., Pawlikowski M., Stepien H., and Janecka A. Inhibitory effect of thyrotropin releasing hormone on spontaneous proliferation of mouse spleen lymphocytes in vitro. Biochem Biophys Res Commun 181 2 (1991) 562-565
38. Lechan R.M. Update on thyrotropin-releasing hormone. Thyroid Today 16 (1993) 1-11
39. Lesnikov V.A., Korneva E.A., Dall'ara A., and Pierpaoli W. The involvement of pineal gland and melatonin in immunity and aging: II. Thyrotropin-releasing hormone and melatonin forestall involution and promote reconstitution of the thymus in anterior hypothalamic area (AHA)-lesioned mice. Int J Neurosci 62 1-2 (1992) 141-153
40. Lynn R.B., Feng H.S., Han J., and Brooks F.P. Gastric effects of thyrotropin-releasing hormone microinjected into the dorsal vagal nucleus in cats. Life Sci 48 13 (1991) 1247-1254
41. Marquette C., Linard C., Galonnier M., Van Uye A., Mathieu J., Gourmelon P., et al. IL-1beta, TNFalpha and IL-6 induction in the rat brain after partial-body irradiation: role of vagal afferents. Int J Radiat Biol 79 10 (2003) 777-785
42. Martino E., Nardi M., Vaudagna G., Simonetti S., Cilotti A., Piunchera A., et al. Thyrotropin-releasing hormone-like material in human retina. J Endocrinol Invest 3 (1980) 267-271
43. Matre V., Høvring P.I., Fjeldheim A.K., Helgeland L., Orvain C., Andersson K.B., et al. The human neuroendocrine thyrotropin-releasing hormone receptor promoter is activated by the haematopoietic transcription factor c-Myb. Biochem J 372 Pt 3 (2003) 851-859
44. Mellado M., Fernández-Agulló T., Rodríguez-Frade J.M., San Frutos M.G., de la Peña P., Martínez-A C., et al. Expression analysis of the thyrotropin-releasing hormone receptor (TRHR) in the immune system using agonist anti-TRHR monoclonal antibodies. FEBS Lett 28 451(3) (1999) 308-314
45. Miller A.H., Ancoli-Israel S., Bower J.E., Capuron L., and Irwin M.R. Neuroendocrine-immune mechanisms of behavioral comorbidities in patients with cancer. J Clin Oncol 26 6 (2008) 971-982
46. Monk J.P., Phillips G., Waite R., Kuhn J., Schaff L.J., Otterson G.A., et al. Assessment of tumor necrosis factor alpha blockade as an intervention to improve tolerability of dose-intensive chemotherapy in cancer patients. J Clin Oncol 24 12 (2006) 1852-1859
47. Montagne J.J., Ladram A., Grouselle D., Nicolas P., and Bulant M. Thyrotropin-releasing hormone immunoreactivity in rat adrenal tissue is localized in mast cells. J Histochem Cytochem 45 12 (1997) 1623-1627
48. Montagne J.J., Ladram A., Nicolas P., and Bulant M. Cloning of thyrotropin-releasing hormone precursor and receptor in rat thymus, adrenal gland, and testis. Endocrinology 140 3 (1999) 1054-1059
49. Morrow N.S., Quinonez G., Weiner H., Taché Y., and Garrick T. Interleukin-1 beta in the dorsal vagal complex inhibits TRH analogue-induced stimulation of gastric contractility. Am J Physiol 269 2 Pt 1 (1995) G196-202
50. Nagy E., and Berczi I. Immunodeficiency in hypophysectomized rats. Acta Endocrinol 89 3 (1978) 530
51. Nash P.T., and Florin T.H. Tumour necrosis factor inhibitors. Med J 183 4 (2005) 205-208
52. Nillni E.A., and Sevarino K.A. The biology of pro-thyrotropin-releasing hormone-derived peptides. Endocr Rev 20 5 (1999) 599-648
53. Pang X.P., Hershman J.M., Mirell C.J., and Pekary A.E. Impairment of hypothalamic-pituitary-thyroid function in rats treated with human recombinant tumor necrosis factor-alpha (cachectin). Endocrinology 125 1 (1989) 76-84
54. Pavlov V.A., and Tracey K.J. Neural regulators of innate immune responses and inflammation. Cell Mol Life Sci 61 18 (2004) 2322-2331
55. Pawlikowski M., Stepien H., and Komorowski J. Hypothalamic-pituitary-thyroid axis and the immune system. Neuroimmunomodulation 1 3 (1994) 149-152
56. Pawlikowski M., Zerek-Mełeń G., and Winczyk K. Thyroliberin (TRH) increases thymus cell proliferation in rats. Neuropeptides 23 3 (1992) 199-202
57. Pekary A.E., Stevens S.A., and Sattin A. Lipopolysaccharide modulation of thyrotropin-releasing hormone (TRH) and TRH-like peptide levels in rat brain and endocrine organs. J Mol Neurosci 31 3 (2007) 245-259
58. Perez C.C., Penaleva R., Paez P.M., Renner U., Reul J.M., Stalla G.K., et al. Early activation of thyrotropin-releasing-hormone and prolactin plays a critical role during a T cell-dependent immune response. Endocrinology 140 2 (1999) 690-697
59. Pierpaoli W., and Yi C. The involvement of pineal gland and melatonin in immunity and aging. I. Thymus-mediated, immunoreconstituting and antiviral activity of thyrotropin-releasing hormone. J Neuroimmunol 27 2-3 (1990) 99-109
60. Porter M.H., Hrupka B.J., Langhans W., and Schwartz G.J. Vagal and splanchnic afferents are not necessary for the anorexia produced by peripheral IL-1beta, LPS, and MDP. Am J Physiol 275 2 Pt 2 (1998) R384-389
61. Raiden S., Polack E., Nahmod V., Labeur M., Holsboer F., and Arzt E. TRH receptor on immune cells: in vitro and in vivo stimulation of human lymphocyte and rat splenocyte DNA synthesis by TRH. J Clin Immunol 15 5 (1995) 242-249
62. Raison C.L., Capuron L., and Miller A.H. Cytokines sing the blues: inflammation and the pathogenesis of depression. Trends Immunol 27 1 (2006) 24-31
63. Rychly D.J., and DiPiro J.T. Infections associated with tumor necrosis factor-alpha antagonists. Pharmacotherapy 25 9 (2005) 1181-1192
64. Santos J., Saperas E., Mourelle M., Antolín M., and Malagelada J.R. Regulation of intestinal mast cells and luminal protein release by cerebral thyrotropin-releasing hormone in rats. Gastroenterology 111 6 (1996) 1465-1473
65. Sawchenko P.E., Li H.Y., and Ericsson A. Circuits and mechanisms governing hypothalamic responses to stress: a tale of two paradigms. Prog Brain Res 122 (2000) 61-78
66. Schettini G., Grimaldi M., Landolfi E., Meucci O., Ventra C., Florio T., et al. Role of interleukin-6 in the neuroendocrine system. Acta Neurol (Napoli) 13 4 (1991) 361-367
67. Serebrov V., Zobnina M.N., and Tikhonova N.M. Structural-functional state of the thyroid gland after thymectomy. Biull Eksp Biol Med 114 9 (1992) 329-332
68. Shih A., and Jackson II K.C. Role of corticosteroids in palliative care. J Pain Palliat Care Pharmacother 21 4 (2007) 69-76
69. Shimanko I.I., Limarev V.M., Ashmarin I.P., Lelekova T.V., and Sanzhieva L.T. The use of thyrotropin-releasing hormone in clinical practice as a lymphatic stimulator in the treatment of acute pancreatitis. Khirurgiia (Mosk) 1 (1992) 64-66
70. Stephens R.L., Ishikawa T., Weiner H., Novin D., and Tache Y. TRH analogue, RX 77368, injected into dorsal vagal complex stimulates gastric secretion in rats. Am J Physiol 254 5 Pt 1 (1988) G639-643
71. Sternberg E.M. Neuroendocrine factors in susceptibility to inflammatory disease: focus on the hypothalamic-pituitary-adrenal axis. Horm Res 43 4 (1995) 159-161
72. Sun Y., Lu X., and Gershengorn M.C. Thyrotropin-releasing hormone receptors - similarities and differences. J Mol Endocrinol 30 2 (2003) 87-97
73. Taché Y., and Yoneda M. Central action of TRH to induce vagally mediated gastric cytoprotection and ulcer formation in rats. J Clin Gastroenterol 17 Suppl 1 (1993) S58-63
74. Taché Y., Yang H., Miampamba M., Martinez V., and Yuan P.Q. Role of brainstem TRH/TRH-R1 receptors in the vagal gastric cholinergic response to various stimuli including sham-feeding. Auton Neurosci 125 1-2 (2006) 42-52
75. Trejbal D., Petrasova D., and Wagnerova H. Prolactin and interleukin 2 concentrations before and after i.v. TRH application in primary hypothyroidism and in controls. Bratisl Lek Listy 102 9 (2001) 417-419
76. van Haasteren G.A., van der Meer M.J., Hermus A.R., Linkels E., Klootwijk W., Kaptein E., et al. Different effects of continuous infusion of interleukin-1 and interleukin-6 on the hypothalamic-hypophysial-thyroid axis. Endocrinology 135 4 (1994) 1336-1345
77. Wang J., and Klein J.R. Hormonal regulation of extrathymic gut T cell development: involvement of thyroid stimulating hormone. Cell Immunol 161 2 (1995) 299-302
78. Wang J., Whetsell M., and Klein J.R. Local hormone networks and intestinal T cell homeostasis. Science 275 5308 (1997) 1937-1939
79. Winokur A., and Utiger R.D. Thyrotropin-releasing hormone: regional distribution in rat brain. Science 185 (1974) 265-266
80. Wittman G.J. Regulation of hypophysiotropic corticotropin-releasing hormone and thyrotropin-releasing hormone-synthesizing neurons by brainstem catecholaminergic neurons. Neuroendocrinol 7 (2008) 952-960
81. Wieczorek M., Swiergiel A.H., Pournajafi-Nazarloo H., and Dunn A.J. Physiological and behavioral responses to interleukin-1beta and LPS in vagotomized mice. Physiol Behav 85 4 (2005) 500-511
82. Winczyk K., and Pawlikowski M. Time of day-dependent effects of thyroliberin and thyrotropin on thymocyte proliferation in rats. Neuroimmunomodulation 7 2 (2000) 89-91
83. Yamada M., Shibusawa N., Hashida T., Ozawa A., Monden T., Satoh T., et al. Expression of thyrotropin-releasing hormone (TRH) receptor subtype 1 in mouse pancreatic islets and HIT-T15, an insulin-secreting clonal beta cell line. Life Sci 66 12 (2000) 1119-1125
84. Yarbrough G.G. On the neuropharmacology of thyrotropin releasing hormone (TRH). Prog Neurobiol 12 3-4 (1979) 291-312
85. Yarbrough G.G., Kamath J., Winokur A., and Prange Jr. A.J. Thyrotropin-releasing hormone (TRH) in the neuroaxis: therapeutic effects reflect physiological functions and molecular actions. Med Hypotheses 69 6 (2007) 1249-1256
86. Yoneda M., Hoshimoto T., Nakamura K., Tamori K., Yokohama S., Kono T., et al. Thyrotropin-releasing hormone in the dorsal vagal complex stimulates hepatic blood flow in rats. Hepatology 38 6 (2003) 1500-1507
87. Yoneda M., Goto M., Nakamura K., Yokohama S., Kono T., Tanamo M., et al. Thyrotropin-releasing hormone in the dorsal vagal complex stimulates pancreatic blood flow in rats. Regul Pept 131 1-3 (2005) 74-81
88. Yoneda M., Goto M., Nakamura K., Shimada T., Hiraishi H., Terano A., et al. Protective effect of central thyrotropin-releasing hormone analog on cerulein-induced acute pancreatitis in rats. Regul Pept 125 1-3 (2005) 119-124
89. Yu-Lee L.Y. Prolactin modulation of immune and inflammatory responses. Recent Prog Horm Res 57 (2002) 435-455